Marine compounds in the treatment of Alzheimer’s disease
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
| Autor principal: | |
|---|---|
| Outros Autores: | |
| Formato: | Thesis |
| Idioma: | English |
| Publicado em: |
Brac University
2022
|
| Assuntos: | |
| Acesso em linha: | http://hdl.handle.net/10361/17302 |
| id |
10361-17302 |
|---|---|
| record_format |
dspace |
| spelling |
10361-173022022-09-26T21:01:59Z Marine compounds in the treatment of Alzheimer’s disease Parveen, Sanjana Yasmin, Hasina Department of Pharmacy, Brac University Marine compounds Bryostatin-1 Homotaurine Dictyostatin Docohexanoic acid Alzheimer’s disease This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022. Cataloged from PDF version of thesis report. Includes bibliographical references (pages 60-89). Brain shrinkage and cell death occurs due to Alzheimer's disease, a degenerative neurologic illness. Memory loss, social and behavioral deterioration, and the inability to operate independently are all symptoms of Alzheimer's disease, which is the most frequent cause of dementia. The accumulation of beta amyloid plaque and neurofibrillary tangles are the hallmarks of alzheimer’s disease and conventional treatments only aim to soothe symptoms rather than treat or prevent disease. Presently, the scientific community is working together to find innovative natural compounds that are helpful against Alzheimer's disease and marine natural products have been demonstrated to be potential possibilities. Currently bryostatin-1, homotaurine, dictyostatin, docohexanoic acid, rifampicin, gracilins are being tested for alzheimer’s disease. More clinical trials need to be conducted for marine compounds to be used in alzheimer’s patient. Along with that combination therapy consisting of marine compounds have a prospect of displaying better activity that need to be tested. Sanjana Parveen B. Pharmacy 2022-09-26T05:17:17Z 2022-09-26T05:17:17Z 2022 2022-03 Thesis ID 17346003 http://hdl.handle.net/10361/17302 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 89 pages application/pdf Brac University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
Marine compounds Bryostatin-1 Homotaurine Dictyostatin Docohexanoic acid Alzheimer’s disease |
| spellingShingle |
Marine compounds Bryostatin-1 Homotaurine Dictyostatin Docohexanoic acid Alzheimer’s disease Parveen, Sanjana Marine compounds in the treatment of Alzheimer’s disease |
| description |
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022. |
| author2 |
Yasmin, Hasina |
| author_facet |
Yasmin, Hasina Parveen, Sanjana |
| format |
Thesis |
| author |
Parveen, Sanjana |
| author_sort |
Parveen, Sanjana |
| title |
Marine compounds in the treatment of Alzheimer’s disease |
| title_short |
Marine compounds in the treatment of Alzheimer’s disease |
| title_full |
Marine compounds in the treatment of Alzheimer’s disease |
| title_fullStr |
Marine compounds in the treatment of Alzheimer’s disease |
| title_full_unstemmed |
Marine compounds in the treatment of Alzheimer’s disease |
| title_sort |
marine compounds in the treatment of alzheimer’s disease |
| publisher |
Brac University |
| publishDate |
2022 |
| url |
http://hdl.handle.net/10361/17302 |
| work_keys_str_mv |
AT parveensanjana marinecompoundsinthetreatmentofalzheimersdisease |
| _version_ |
1814308476386541568 |